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Background: Non-invasive measurement of oxygenation is routine in adult clinical
practice but transcutaneous monitoring of PCO2 (PtcCO2) is used much less due to
technical difﬁculties with earlier transcutaneous electrodes.
Objective: Our aim was to determine the reliability of estimating arterial PCO2
(PaCO2) using a recently introduced combined SaO2/PtcCO2 monitor (‘‘TOSCA’’,
Linde Medical Systems) in adult patients in routine clinical respiratory practice.
Methods: PtcCO2 was measured in patients requiring arterial blood gases for clinical
reasons. Ten minutes after the probe had been attached to an earlobe PtcCO2 was
recorded, immediately before arterial blood sampling. The PCO2 values obtained
were compared by Bland–Altman analysis.
Results: Samples were taken from 48 unselected patients with varied pathology.
There were no technical problems. Median age was 56 years (range 20–86 years). The
mean difference between PaCO2 and PtcCO2 was 0.04 kPa, SD of the difference
0.67 kPa. Bland–Altman analysis showed generally good agreement between the two
measurements across the range of PaCO2 values (4–10.9 kPa). Four of 48
measurements showed a PCO2 difference 41 kPa with no technical or clinical
explanations apparent.
Conclusions: The accuracy of estimation of PaCO2 by the TOSCA transcutaneous
electrode was generally good and the device appears promising for use in routine
clinical respiratory practice.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Non-invasive estimation of arterial PCO2 by mea-
surement of transcutaneous carbon dioxide
(PtcCO2) has been possible since 1972 but for many
years measurement of PtcCO2 was inaccurate and
impracticable with sensors being fragile and ex-
pensive and requiring frequent calibration.1 More
recent PtcCO2 monitors have proved to be more
reliable and are routinely used in infants but are
not widely used in adult patients. If accurate they
would usefully complement the ‘gold standard’
measurement of arterial blood gases which is
invasive, intermittent and may be unpleasant.
Preliminary studies of the reliability of a combined
PtcCO2/SpO2 monitor (TOSCA, Linde Medical Sen-
sors, Basel, Switzerland) have shown good agree-
ment in adult volunteers and anaesthetised
adults.2–4 The current TOSCA sensor has been
evaluated in anaesthetised children,5 anaesthe-
tised adults6 and ill neonates7 with all these studies
again showing good agreement between PtcCO2 and
PaCO2. However, one study involving acutely ill
adult patients receiving intensive care8 suggested a
signiﬁcant difference between measured PtcCO2
and PaCO2, but this study included only a small
number of subjects (n ¼ 8) with multiple measure-
ments from individuals.
To our knowledge no studies have been reported
evaluating the accuracy of the TOSCA monitor in
adult patients in routine respiratory practice. We
have therefore determined the reliability of esti-
mating PaCO2 using the TOSCA monitor in unse-
lected adult patients in routine respiratory
practice.3 6 9 12
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Figure 1 (a) Comparison of transcutaneous and arterial PCO2
plot of difference between 2 estimates of PCO2 and their avMethods
After approval from the Local Research Ethics
Committee and obtaining informed patient consent,
we prospectively enrolled 48 patients into the
study. All were inpatients in a respiratory ward
(including general and subspecialty respiratory
medicine) who required arterial blood gas analysis
for clinical reasons. A detailed technical description
of how the TOSCA sensor works is provided else-
where.5 PtcCO2 is measured (along with SpO2) via a
sensor attached by a low-pressure clip to an
earlobe. The sensor probe heats the earlobe to
42 1C to enhance blood ﬂow. After automated
calibration the TOSCA sensor was attached to an
earlobe to monitor PtcCO2; after 10min PtcCO2 was
recorded immediately prior to arterial blood sam-
pling for blood gas analysis in the usual way (Gem
Premier 3000, Instrumentation Laboratory, Lexing-
ton, MA, USA). Co variables recorded included
inspired oxygen concentration, diagnosis, age,
gender, heart rate, blood pressure, temperature
and any technical problems with the measurement.
Statistical analysis
The level of agreement between PaCO2 and PtcCO2
measured by TOSCA was assessed by Bland–Altman
analysis.9Results
Forty-eight adult patients were recruited prospec-
tively. Their median age was 56 years (range3 5 7 9 11
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Table 1 Individual PaCO2 and PtcCO2 values in 48
patients.
PaCO2 (kPa) PtcCO2 Difference
5.9 6.4 0.5
5.3 5 0.3
4.8 4.7 0.1
8.3 7.5 0.8
5.1 4.9 0.2
5.2 5.6 0.4
7 6.7 0.3
6.5 6.1 0.4
9.7 10.5 0.8
5.2 5 0.2
5.6 5.4 0.2
5.2 4.9 0.3
5.3 5.6 0.3
4.7 4.8 0.1
8.3 8.1 0.2
5.1 4.9 0.2
5.5 3.5 2
4.8 5 0.2
4.7 5 0.3
4.7 5.6 0.9
9.6 9.5 0.1
5.6 5.7 0.1
6.1 6.8 0.7
5.2 5.3 0.1
4 4.2 0.2
6 6.1 0.1
5.9 5.2 0.7
8 8.9 0.9
4.5 4.5 0
4.7 4.5 0.2
7.3 7.2 0.1
4.4 4.7 0.3
6.4 6.7 0.3
7.1 6.8 0.3
5.7 8.3 2.6
4.1 4.2 0.1
5.3 5.2 0.1
5.7 5.6 0.1
5.2 5.5 0.3
5.6 5.7 0.1
5.1 6.3 1.2
9.3 9.1 0.2
5.1 5.1 0
10.9 9.2 1.7
4.1 4 0.1
6.3 6 0.3
5.6 5.9 0.3
6.8 7.2 0.4
Evaluation of a transcutaneous carbon dioxide monitor 26320–86). Subjects had a wide variety of diagnoses
including; chronic obstructive pulmonary disease
(n ¼ 20), cystic ﬁbrosis (n ¼ 9), pulmonary ﬁbrosis
(n ¼ 5), primary pulmonary hypertension (n ¼ 4),
bronchiectasis, extrinsic allergic alveolitis andchronic thromboembolic pulmonary hypertension
(n ¼ 2 each), acute pulmonary embolism, histiocy-
tosis X, obliterative bronchiolitis and respiratory
muscle weakness (n ¼ 1 each). The group included
both acutely ill and clinically stable patients and
each patient was reported once only. Only 4
patients had an arterial pHo7.35, all with chronic
obstructive pulmonary disease. Mean difference
between PaCO2 and PtcCO2 was 0.04 kPa with a
standard deviation of the difference of 0.67 kPa.
Bland–Altman analysis showed generally good
agreement between the two measurements
(Fig. 1(b)) across the range of PaCO2 values
recorded (4–10.9 kPa). Four of 48 measurements
showed a PCO2 difference of 41 kPa. No technical
problems were experienced (Table 1).Discussion
We have evaluated the accuracy of the TOSCA sensor
for non-invasive estimation of arterial carbon dioxide
in adult patients in a general respiratory ward. Our
results show generally good agreement between
PtcCO2 measured by TOSCA and PaCO2 measured
from sampling arterial blood. The monitor is simple
to use and appears promising for use in adult
respiratory practice within its limitations. Clearly,
measurements of PtcCO2 are not as informative as
arterial blood gases (e.g. it does not measure pH or
HCO3
) and isolated elevated CO2 levels give an
incomplete picture, for instance in patients with
chronic type 2 respiratory failure. Measurements of
PtcCO2 should be used in conjunction with arterial
blood gas measurement, particularly for following
trends after an initial arterial sample has been taken,
the main advantages being that it provides a
continuous measurement and reduces the need for
frequent invasive sampling of arterial blood. Our
study did not assess the accuracy of the TOSCA
monitor when used to follow trends in PaCO2 over
time as only one comparison was made. We chose to
make one baseline comparison of PaCO2 and PtcCO2
because a large number of patients in the study
required only a single arterial blood sample and to
avoid the possibility of intrasubject variation con-
founding the analysis. Further studies examining the
accuracy of the TOSCA sensor when used continuously
over an extended time period are required.
A discrepancy of 41 kPa between PtcCO2 and
PaCO2 was seen in 4/48 subjects; the reason for this
is unclear with no common factor apparent. As no
repeat comparisons were made, it was not clear
whether the discrepancies were consistent within
individuals.
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were clinically stable with only 4/48 subjects
having an arterial pHo7.35, although a wide range
of PCO2 values were recorded. Further studies
assessing the accuracy and usefulness of the TOSCA
sensor in patients with acute respiratory failure
would be useful as this is the group of patients who
may beneﬁt most from using this device.
There have been concerns in the past regarding
the safety of transcutaneous CO2 monitors as
heated probes have caused cutaneous blistering
when used for prolonged periods. The manufac-
turer states that the probe is safe for continuous
use as long as it is changed to the opposite ear
every 12 h. We encountered no safety issues but we
did not set out to investigate continuous monitoring
over an extended time period. We conclude that
the accuracy of the TOSCA sensor used in adult
patients in routine respiratory practice is good and
the device appears promising for use in this setting.References
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